User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
This article was originally published in The Pink Sheet Daily
Executive Summary
The draft proposal is expected to be a stand-alone clause, not technically part of next year's reauthorization of the Prescription Drug User Fee Act.